Scoping Review Data on Hormonal Contraception and Psychiatric Comorbidities

A scoping review document summarizing findings from 46 studies published between 2014 and 2024 on associations between hormonal contraception and psychiatric outcomes. The review, authored by Amélie Poirier, includes pooled meta-analyses for depressive symptoms, suicidality, and anxiety. The document was last updated on 2026-06-01.

Use Cases

• Conducting secondary analysis based on the pooled risk ratios for depressive symptoms (RR = 1.24) and suicidality (RR = 1.20) reported in the review.
• Assessing methodological heterogeneity and confounding factors in studies on contraception and mental health as described in the results.
• Identifying research gaps for future prospective studies with standardized psychiatric measures as suggested in the discussion.

Strengths

• The review is based on 46 peer-reviewed studies identified from a comprehensive search of four major databases.
• Includes specific pooled effect estimates, such as RR = 1.24 for depressive symptoms and RR = 1.20 for suicidality.
• Study quality was assessed using the Joanna Briggs Institute checklist.

Limitations

• The dataset is a 27.2 KB DOCX document; its structured data content and column-level details are unknown.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

figshare

Collection Method

Scoping review and meta-analysis of existing peer-reviewed studies.

Time Range

Studies published between 2014 and 2024.

Freshness

Last updated 2026-06-01 05:25:23; freshness should be verified.